{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:35:37Z","timestamp":1773689737245,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T00:00:00Z","timestamp":1688083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.bcp.2023.115678","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T10:58:07Z","timestamp":1688209087000},"page":"115678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma"],"prefix":"10.1016","volume":"214","author":[{"given":"Valentina","family":"Cocc\u00e8","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Bonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"La Monica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Doneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Martegani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Alessandri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costanza Annamaria","family":"Lagrasta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Giann\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Sordi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leda","family":"Roncoroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Paino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2023.115678_b0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09059180.00007014","article-title":"Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic","volume":"24","author":"R\u00f8e","year":"2015","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.bcp.2023.115678_b0010","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jtho.2018.06.011","article-title":"Scientific advances and new frontiers in mesothelioma therapeutics","volume":"13","author":"Mutti","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2023.115678_b0015","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2023.115678_b0020","first-page":"1","article-title":"An update on emerging therapeutic options for malignant pleural mesothelioma","volume":"13","author":"Davis","year":"2022","journal-title":"Lung Cancer: Target Therapy"},{"key":"10.1016\/j.bcp.2023.115678_b0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2009.02.011","article-title":"Na\u00efve Human Umbilical Cord Matrix Derived Stem Cells Significantly Attenuate Growth of Human Breast Cancer Cells in Vitro and in Vivo","volume":"280","author":"Ayuzawa","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2023.115678_b0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/aps.2013.50","article-title":"Mesenchymal Stem Cells: A New Trend for Cell Therapy","volume":"34","author":"Wei","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2023.115678_b0035","first-page":"3603","article-title":"Bone Marrow-Derived Mesenchymal Stem Cells as Vehicles for Interferon-\u03b2 Delivery into Tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2023.115678_b0040","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1073\/pnas.0806647106","article-title":"Assessment of Therapeutic Efficacy and Fate of Engineered Human Mesenchymal Stem Cells for Cancer Therapy","volume":"106","author":"Sasportas","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2023.115678_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-015-0200-3","article-title":"Drug-Releasing Mesenchymal Cells Strongly Suppress B16 Lung Metastasis in a Syngeneic Murine Model","volume":"34","author":"Pessina","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.bcp.2023.115678_b0050","doi-asserted-by":"crossref","first-page":"e28321","DOI":"10.1371\/journal.pone.0028321","article-title":"Mesenchymal Stromal Cells Primed with Paclitaxel Provide a New Approach for Cancer Therapy","volume":"6","author":"Pessina","year":"2011","journal-title":"PLoS One"},{"issue":"1 Suppl","key":"10.1016\/j.bcp.2023.115678_b0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/03946320130260S105","article-title":"Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity","volume":"26","author":"Bonomi","year":"2013","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2023.115678_b0060","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1517\/17425247.2016.1167037","article-title":"Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel","volume":"13","author":"Brini","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bcp.2023.115678_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-016-0282-7","article-title":"Human Lung-Derived Mesenchymal Stem Cell-Conditioned Medium Exerts in Vitro Antitumor Effects in Malignant Pleural Mesothelioma Cell Lines","volume":"7","author":"Cortes-Dericks","year":"2016","journal-title":"Stem Cell Res. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2023.115678_b0070","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/cells10061427","article-title":"Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells","volume":"10","author":"Cocc\u00e8","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2023.115678_b0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.biopha.2017.01.118","article-title":"Paclitaxel-Releasing Mesenchymal Stromal Cells Inhibit in Vitro Proliferation of Human Mesothelioma Cells","volume":"87","author":"Petrella","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2023.115678_b0080","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1432-0436.1988.tb00806.x","article-title":"Characterization of the State of Differentiation of Six Newly Established Human Non-Small-Cell Lung Cancer Cell Lines","volume":"37","author":"Bepler","year":"1988","journal-title":"Differentiation"},{"key":"10.1016\/j.bcp.2023.115678_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13221-016-0037-3","article-title":"Angiogenic and Anti-Inflammatory Properties of Micro-Fragmented Fat Tissue and Its Derived Mesenchymal Stromal Cells","volume":"8","author":"Ceserani","year":"2016","journal-title":"Vasc Cell"},{"key":"10.1016\/j.bcp.2023.115678_b0090","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1568009620666201116112153","article-title":"Paclitaxel Priming of TRAIL Expressing Mesenchymal Stromal Cells (MSCs-TRAIL) Increases Antitumor Efficacy of Their Secretome","volume":"21","author":"Cocc\u00e8","year":"2021","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bcp.2023.115678_b0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bcp.2023.115678_b0100","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/j.1478-3231.2008.01749.x","article-title":"Resveratrol Inhibits Cell Growth in a Human Cholangiocarcinoma Cell Line","volume":"28","author":"Roncoroni","year":"2008","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.bcp.2023.115678_b0105","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.3390\/ijms24065864","article-title":"Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC)","volume":"24","author":"Cordani","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2023.115678_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0653-7","article-title":"Trastuzumab Emtansine Delays and Overcomes Resistance to the Third-Generation EGFR-TKI Osimertinib in NSCLC EGFR Mutated Cell Lines","volume":"36","author":"La Monica","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2023.115678_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1240-x","article-title":"Third Generation EGFR Inhibitor Osimertinib Combined with Pemetrexed or Cisplatin Exerts Long-Lasting Anti-Tumor Effect in EGFR-Mutated Pre-Clinical Models of NSCLC","volume":"38","author":"La Monica","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2023.115678_b0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/bjc.1996.465","article-title":"Paclitaxel for Malignant Pleural Mesothelioma: A Phase II Study of the EORTC Lung Cancer Cooperative Group","volume":"74","author":"Van Meerbeeck","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2023.115678_b0125","first-page":"1","article-title":"Heterogeneity of Paclitaxel Distribution in Different Tumor Models Assessed by MALDI Mass Spectrometry Imaging","volume":"6","author":"Giordano","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2023.115678_b0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/pharmaceutics12050411","article-title":"Automated Large-Scale Production of Paclitaxel Loaded Mesenchymal Stromal Cells for Cell Therapy Applications","volume":"12","author":"Lisini","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2023.115678_b0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jconrel.2014.07.042","article-title":"Paclitaxel Is Incorporated by Mesenchymal Stromal Cells and Released in Exosomes That Inhibit in Vitro Tumor Growth: A New Approach for Drug Delivery","volume":"192","author":"Pascucci","year":"2014","journal-title":"J. Control Release"},{"key":"10.1016\/j.bcp.2023.115678_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00259","article-title":"Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-Tumor Treatment","volume":"9","author":"Chulpanova","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2023.115678_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers11060798","article-title":"Taxol-Loaded MSC-Derived Exosomes Provide a Therapeutic Vehicle to Target Metastatic Breast Cancer and Other Carcinoma Cells","volume":"11","author":"Melzer","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.bcp.2023.115678_b0150","doi-asserted-by":"crossref","DOI":"10.2174\/1871520617666170327113932","article-title":"Fluorescent Immortalized Human Adipose Derived Stromal Cells (HASCs-TS\/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles","volume":"17","author":"Cocce","year":"2017","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.bcp.2023.115678_b0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2019.03.016","article-title":"Microfragmented human fat tissue is a natural scaffold for drug delivery: Potential application in cancer chemotherapy","volume":"302","author":"Alessandri","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bcp.2023.115678_b0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13287-015-0240-9","article-title":"Hu The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy","volume":"6","author":"Zhang","year":"2015","journal-title":"Stem Cell Res. Ther."}],"updated-by":[{"DOI":"10.1016\/j.bcp.2024.116653","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000}}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295223002691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:19:30Z","timestamp":1762096770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295223002691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":32,"alternative-id":["S0006295223002691"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115678","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cells loaded with Paclitaxel (PacliMES) a potential new therapeutic approach on mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2023.115678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115678"}}